Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CEG vs MRNA✓SelectedUSD · MRNACEG vs MRNA performance historyLatest closeAs of-0.78%11/13
Stock and ETF performance explorer

CEG vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+134.7%
MRNA return
+221.0%
Excess return
-86.3%
Maximum drawdown
-50.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.8%-3.4%+2.7%-0.6%
7D+12.1%-12.1%+24.2%+12.7%
30D+0.2%-1.3%+1.5%+0.2%
3M+0.7%+250.9%-250.2%-7.1%
6M+2.2%+343.0%-340.8%-8.7%
YTD-20.3%+657.4%-677.8%-34.0%
1Y-16.1%+794.9%-811.0%-32.2%
3Y+134.7%+218.1%-83.5%+116.3%
All+134.7%+221.0%-86.3%+116.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling